Browaldh Nanna, Bring Johan, Friberg Danielle
Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
Department of ENT Diseases, Karolinska University Hospital, Stockholm, Sweden.
Laryngoscope. 2018 May;128(5):1238-1244. doi: 10.1002/lary.26835. Epub 2017 Sep 1.
Our previous randomized controlled trial of patients with obstructive sleep apnea syndrome (OSAS) showed that modified uvulopalatopharyngoplasty (UPPP), including tonsillectomy, significantly improved nocturnal respiration, daytime sleepiness, and quality of life in the intervention group compared to controls who had delayed surgery after 6 months. This is the continuous report with the 6- and 24-month postoperative results.
Single-center prospective cohort study.
Sixty-five patients with apnea-hypopnea index (AHI) ≥ 15, body mass index (BMI) < 36, Epworth Sleepiness Scale (ESS) ≥ 8, and Friedman stage I or II underwent UPPP after failing nonsurgical treatment. The results from polysomnography and ESS at 6 and 24 months were compared to baseline.
Eight percent and 20% dropped out from the 6- and 24-month follow-ups, respectively. The AHI value decreased significantly from mean (standard deviation) 52.9 (20.5) at baseline to 23.6 (20.2) after 6 months, and to 24.1 (20.9) after 24 months (P < 0.001). Patients with tonsil size 2, and 3 to 4, had significant reductions in the AHI after both follow-ups. The median ESS score decreased significantly from 13 (range 8-21) to 6.5 (1-18) after 6 months, and to 5 (2-17) after 24 months (P < 0.001). The BMI remained unchanged. There were significant modest correlations for the reductions in AHI and ESS after 24 months.
Modified UPPP was effective in improving nocturnal respiration and daytime sleepiness in OSAS patients at both 6- and 24-month follow-up. Patients with tonsil size 2, and 3 to 4, benefitted similarly from surgery with improved respiration.
2b. Laryngoscope, 128:1238-1244, 2018.
我们之前针对阻塞性睡眠呼吸暂停综合征(OSAS)患者开展的随机对照试验表明,与6个月后延迟手术的对照组相比,改良悬雍垂腭咽成形术(UPPP,包括扁桃体切除术)显著改善了干预组患者的夜间呼吸、日间嗜睡及生活质量。这是一份关于术后6个月和24个月结果的连续性报告。
单中心前瞻性队列研究。
65例呼吸暂停低通气指数(AHI)≥15、体重指数(BMI)<36、爱泼沃斯嗜睡量表(ESS)≥8且处于弗里德曼I期或II期的患者在非手术治疗失败后接受了UPPP。将6个月和24个月时多导睡眠图及ESS的结果与基线进行比较。
分别有8%和20%的患者在6个月和24个月的随访中退出。AHI值从基线时的平均(标准差)52.9(20.5)显著降至6个月后的23.6(20.2),以及24个月后的24.1(20.9)(P<0.001)。扁桃体大小为2度以及3至4度的患者在两次随访后AHI均显著降低。ESS评分中位数从6个月时的13(范围8 - 21)显著降至6.5(1 - 18),24个月后降至5(2 - 17)(P<0.001)。BMI保持不变。24个月后AHI和ESS的降低之间存在显著的适度相关性。
改良UPPP在术后6个月和24个月的随访中均有效改善了OSAS患者的夜间呼吸和日间嗜睡。扁桃体大小为2度以及3至4度的患者在手术改善呼吸方面获益相似。
2b。《喉镜》,2018年,第128卷,第1238 - 1244页